Femtosecond Laser Assisted Keratoplasty
FLAK
Comparison of Femtosecond Laser-Assisted and Traditional Keratoplasty for Keratoconus
1 other identifier
interventional
24
1 country
1
Brief Summary
Penetrating keratoplasty (PKP) is corneal transplantation performed by using round trephine blades to create matched circumferential incisions in both the diseased cornea and the donor cornea. The donor tissue graft is then secured in place with sutures which are usually removed postoperatively.The primary surgical goals are the preservation of a clear graft and improvement of vision. Surgical outcomes are limited by donor-recipient junction mismatch, astigmatism, rejection, infection and wound dehiscence. The femtosecond laser is a focusable, infrared laser capable of cutting tissue at various depths and in a range of patterns, and is currently being used to create corneal lamellar flaps in LASIK surgery. The laser parameters can be adjusted for submicron precision in cutting desired diameters, depths and shapes in the cornea, with minimal collateral injury. This technology is now capable of creating full-thickness corneal trephinations with customized locking edges at the graft-host junction between the donor and recipient corneas in Femtosecond Laser-Assisted Keratoplasty (FLAK). This approach may allow for better wound junction of the donor and recipient corneas, which in turn may also significantly reduce astigmatism, improve wound healing and visual recovery. This pilot study will help us determine optimal femtosecond laser spot size, separation, fluence, and energy which result in the best graft-host fit. The specific aim is to investigate postoperative physiology and biomechanics after FLAK in human eyes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 4, 2008
CompletedFirst Posted
Study publicly available on registry
December 5, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedMarch 15, 2017
March 1, 2017
3.2 years
December 4, 2008
March 13, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Investigate postoperative physiology and biomechanics after Femtosecond Laser Assisted Keratoplasty in human eyes.
Preoperatively and 1day, 1week and 1, 3, 6, 12, 18 and 24 months post operatively
Study Arms (2)
FLAK
ACTIVE COMPARATORFemtosecond laser assisted keratoplasty
PKP
ACTIVE COMPARATORPenetrating Keratoplasty
Interventions
Eligibility Criteria
You may qualify if:
- Corneal opacification.
- Reduced ETDRS-measured, best corrected, distance visual acuity to 20/40 or worse.
- Ability to participate in follow-up visits.
- Signed, informed consent.
You may not qualify if:
- Corneal opacification adequately dense to obscure visualization of iris.
- ETDRS-measured, best-corrected, distance visual acuity of 20/30 or better.
- Corneal thickness greater than 1200 µm at the 9 mm peripheral zone.
- Severe corneal thinning including descemetocoele with impending corneal rupture.
- Prior PKP or incisional surgery that may provide a potential space into which the gas produced by the procedure can escape.
- Poor visual potential in the non-study eye (VA of 20/100 or less, without potential for improvement by the examining ophthalmologist's judgment).
- History of glaucoma, including steroid response rise in intraocular pressure.
- Active intraocular inflammation or infection.
- Age 18 or younger.
- Unable to return for scheduled follow-up examinations.
- Other medical condition(s) that will likely prevent long term follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cornea Clinic, Kellogg Eye Center
Ann Arbor, Michigan, 48105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shahzad Mian, MD
University of Michigan Kellogg Eye Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- erry J Bergstrom Collegiate Professor of Resident Education in Ophthalmology and Visual Sciences and Associate Professor of Oph, Ophthalmology & Visual Science
Study Record Dates
First Submitted
December 4, 2008
First Posted
December 5, 2008
Study Start
October 1, 2007
Primary Completion
December 1, 2010
Study Completion
January 1, 2016
Last Updated
March 15, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share